Chimin Health Management Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yunfei Tian

Chief executive officer

CN¥762.0k

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	0.7%
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

CEO

Yunfei Tian (41 yo)

no data

Tenure

CN¥762,000

Compensation

Mr. Yunfei Tian serves as President and Director of Chimin Health Management Co., Ltd. (formerly known as Zhejiang Chimin Pharmaceutical CO.,Ltd). Mr. Tian served as Manager of the Production Department of...

Chimin Health Management Management

Management criteria checks 1/4

Key information

Recent management updates

Chimin Health Management Co., Ltd., Annual General Meeting, May 29, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Chimin Health Management Co., Ltd., Annual General Meeting, May 29, 2024

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.06 in 1Q 2023)

Chimin Health Management Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Chimin Health Management Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.033 in 3Q 2022)

New minor risk - Earnings quality

Chimin Health Management Co., Ltd. (SHSE:603222) announces an Equity Buyback for CNY 120 million worth of its shares.

Second quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.013 loss in 2Q 2022)

Chimin Health Management Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings released: EPS: CN¥0.07 (vs CN¥0.31 in FY 2021)

Now 21% undervalued

Investor sentiment improves as stock rises 15%

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.08 in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.013 loss per share (vs CN¥0.14 profit in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.12 in 1Q 2021)

Less than half of directors are independent

Now 21% undervalued

Investor sentiment improved over the past week

Chimin Health Management Co., Ltd. announced that it expects to receive CNY 900 million in funding

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.099 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.041 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.02 loss in 1Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥9.74

New 90-day low: CN¥10.51

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥30.47

New 90-day high: CN¥39.00

Chimin Health Management Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

Third quarter earnings released

New 90-day high: CN¥37.29

First half earnings released

First half earnings released

New 90-day low - CN¥34.20

Chimin Health Management Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Tenure

Compensation